Scale Patient Registries Without Scaling Costs
Launch and sustain patient registries that grow from dozens to thousands of participants across countries—with infrastructure designed for long-term viability, not just short-term studies.

Why Most Registries Struggle to Scale
Patient registries generate invaluable longitudinal data. Yet traditional infrastructure makes them expensive to launch, difficult to sustain, and nearly impossible to scale affordably.
Infrastructure Built for Registry Scale and Longevity
Carelane provides the foundation for sustainable, multi-year registries that can grow from initial pilots to international programs without infrastructure limitations.

Patient Self-Registration
Enable patients to enroll themselves and contribute data directly through intuitive interfaces. Reduce site burden by 50-85% while improving data timeliness and completeness. Participants can complete assessments from home, maintaining engagement even when clinic visits aren't required.

Long-Term Follow-Up
Maintain registry engagement over years, not just months. Flexible data collection, and integrated tools reduce manual coordination effort by 70-95%. Allowing your team to focus attention where it matters most.

Rapid Multi-Site Activation
Launch registries in weeks, not months. Our customers activate up to 60 sites in a single week across multiple countries. The site self-registration workflows and automated capability assessment reduce site onboarding time by 60-90%, enabling you to build momentum during critical launch windows.

Cost Structure That Scales
Transparent, sustainable pricing allows registries to grow without financial constraints. Whether you're managing 100 participants or 10,000, your infrastructure costs remain predictable and proportional, not exponential.
Proven at Scale Across Disease Areas
Patient registries worldwide are using Carelane to collect high-quality longitudinal data while maintaining operational and financial sustainability.
- 60-90% reduction in site activation time
- 50-85% decrease in site data entry burden
The Strategic Value of Scalable Registries
Patient registries are increasingly recognized as essential infrastructure for understanding disease natural history, evaluating interventions, and supporting regulatory decisions—when data quality and scale meet modern standards.
Registries as Research Infrastructure
Regulatory bodies and payers increasingly look to registry data for real-world evidence. Well-designed registries can support drug approvals, coverage decisions, and clinical guideline development, but only if they achieve sufficient scale and data quality.
Long-Term Sustainability Requirements
Unlike fixed-duration trials, registries must remain viable for 5, 10, or 20+ years. Infrastructure economics must support sustained operations without requiring continuous fundraising solely to maintain systems.
Patient-Centered Data Collection
Modern participants expect to contribute data on their terms, through mobile devices, between clinic visits, and with minimal burden. Registries that don't accommodate patient preferences face declining enrollment and retention.
Ready to try Carelane?
The only end-to end solution for observational trials.
Unlock research at scale, slashing costs, complexity and friction!

